In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples